JAMA Neurology

Papers
(The H4-Index of JAMA Neurology is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Diplopia and Ptosis in an Older Woman472
Somebody to Love450
Early Posttraumatic Seizures—Putting Things in Perspective437
Optimizing the Time Course of Risks and Benefits of Acute Dual Antiplatelet Therapy for Stroke Prevention385
Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy353
Equipping AI for Unbiased and Inclusive Neurology342
Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration222
Error in Author Name220
Rizatriptan vs Placebo for Attacks of Vestibular Migraine219
Origin of Transthyretin in Cerebral Amyloid Angiopathy216
Association Between Increased Seizures During Rewarming After Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up212
Automated Imaging Differentiation for Parkinsonism204
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation199
Ghrelin for Neuroprotection in Post–Cardiac Arrest Coma198
Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis198
Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance196
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation187
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis182
A Call to Action to Address Sex Differences in Alzheimer Disease Clinical Trials176
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis176
Magnetic Resonance Imaging Features of Tropical Candidal Meningoencephalitis173
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach165
JAMA Neurology165
JAMA Neurology165
Is It Really Itching?150
The Neurologist’s Imperative in Brain Death149
Teleneurorehabilitation and Motor and Nonmotor Symptoms and Quality of Life in Parkinson Disease146
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis142
Time to Change the Current Clinical Classification of Multiple Sclerosis?139
Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke134
Anticoagulation and Antiplatelet Therapy in Patients With Atrial Fibrillation and Atherosclerosis133
Thrombolysis With Tenecteplase for Minor Disabling Stroke131
Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts131
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease131
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers128
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation125
Retinal Hemorrhage Associated with Human Granulocytic Anaplasmosis122
N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy121
Error in Abstract116
Do Neurologists Need a Goldwater Rule?108
Disentangling Workflow Paradigms and Treatment Decision-making in Acute Ischemic Stroke108
Histologic Anatomy of Neurocysticercosis105
Error in Figure104
Spontaneous AICA Dissection Presenting With Isolated Audiovestibular Loss99
Error in Additional Contributions99
Functional Seizures—A Critical Comorbidity Overlooked in Epilepsy Research—Reply98
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease96
Is It Really Itching?—Reply95
Sleep Recording for the Diagnosis and Treatment of Paraplegia95
Association of Cardiovascular Events With Spouse’s Subsequent Dementia95
Error in Figure93
Spinal Cerebrospinal Fluid Leak Mimicking a Cerebellopontine Angle Tumor93
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions93
JAMA Neurology93
Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy91
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core91
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment91
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease88
Role of the X Chromosome in Alzheimer Disease Genetics87
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias87
Methylphenidate for Apathy in Alzheimer Disease—Why Should We Care?87
Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy84
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke83
Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion82
Visual Neglect After an Isolated Lesion of the Superior Colliculus82
Intra-Arterial Tenecteplase After Successful Reperfusion in Large Vessel Occlusion Stroke82
Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy82
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum81
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology81
JAMA Neurology81
JAMA Neurology80
Error in Text78
Perceived CTE and Suicidality—Is Perception Reality?77
Error in Figures76
Acute Myelopathy in a Man With Cutaneous Papules76
Behavioral Compared With Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease75
Error in Key for Figure 375
0.064524173736572